SCHEMBL10288359

SCHEMBL10288359

COc1ccc(Cn2c(-c3ccncc3)cc(=O)n(Cc3ccc(OC)cc3)c2=O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 1/20 0.59
▸ MAPT P10636 5/20 0.45
▸ THRB P10828 1/20 0.45
▸ LSS P48449 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ CMA1 P23946 1/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ CYP11B1 P15538 1/20 0.42
▸ CYP11B2 P19099 1/20 0.42
▸ P2RX4 Q99571 1/20 0.42
▸ DCTPP1 Q9H773 1/20 0.41
▸ GSK3A P49840 1/20 0.41
▸ GSK3B P49841 1/20 0.41
▸ GABRA5 P31644 1/20 0.41
▸ RGS4 P49798 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18931688 0.86 RGS4 (0.53) PDE5AMAPTALDH1A1KDM4EALOX15
SCHEMBL12836975 0.85 PIK3CD (0.53) PDE5AMAPTTHRBALDH1A1CYP11B1
SCHEMBL18931672 0.84 RGS4 (0.52) MAPTALDH1A1KDM4EP2RX4RGS4
SCHEMBL12158761 0.79 OPRK1 (0.50) PDE5AMAPTTHRBALDH1A1P2RX4
SCHEMBL325964 0.78 KDM4E (0.50) PDE5AMAPTTHRBALDH1A1KDM4E
SCHEMBL325963 0.78 KDM4E (0.50) PDE5AMAPTTHRBALDH1A1KDM4E
SCHEMBL10254576 0.78 KDM4E (0.50) PDE5AMAPTTHRBALDH1A1KDM4E
SCHEMBL10254906 0.78 PDE5A (0.49) PDE5AMAPTTHRBALDH1A1KDM4E
SCHEMBL325735 0.76 MAPT (0.51) PDE5AMAPTTHRBALDH1A1KDM4E
SCHEMBL4769071 0.76 ALDH1A1 (0.60) MAPTALDH1A1KDM4EALOX15CMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8372973-B2 Prokineticin 1 receptor antagonists JANSSEN PHARMACEUTICA N.V. (BE) 2013-02-12 — — US disclosed
US-20120028997-A1 PROKINETICIN 1 RECEPTOR ANTAGONISTS COATS STEVEN J (US) 2012-02-02 — — US disclosed
US-20110319400-A1 PROKINETICIN 1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN JANSSEN PHARMACEUTICA, NV (BE) 2011-12-29 — — US disclosed
US-7902358-B2 Gastrointestinal disorders; inflammatory bowel disorders; gastroesophageal reflux, constipation; diarrhea JANSSEN PHARMACEUTICA NV (BE) 2011-03-08 — — US disclosed
US-20080287445-A1 Prokineticin 2 receptor antagonists JANSSEN PHARMACEUTICA N.V. (BE) 2008-11-20 — — US disclosed
US-20080269225-A1 Prokineticin 1 receptor antagonists JANSSEN PHARMACEUTICA N.V. (BE) 2008-10-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028997-A1 PROKINETICIN 1 RECEPTOR ANTAGONISTS PROKR1, PROKR2, GIPR PDE5A 1025/4885MAPT 4202/4885THRB 438/4885
US-20110319400-A1 PROKINETICIN 1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN PROKR1, OPRL1, PROKR2 PDE5A 1105/4885MAPT 4365/4885THRB 1469/4885
US-20080269225-A1 Prokineticin 1 receptor antagonists PROKR1, PROKR2, GIPR PDE5A 1025/4885MAPT 4202/4885THRB 438/4885
US-20080287445-A1 Prokineticin 2 receptor antagonists PROKR2, PROKR1, GIPR PDE5A 1028/4885MAPT 4090/4885THRB 324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback